Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Generic cefaclor approved in the U.S.

Sep. 27, 1996

Takeda develops new pediatric formulation of Firstcin

Sep. 27, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Sixteenth approval for Amphotec

Sep. 20, 1996

New topical triazole antifungal agent from Kaken

Sep. 20, 1996

Optically active triazole antifungal agent from Takeda

Sep. 20, 1996

Antifungal cyclohexapeptides from Merck & Co.

Sep. 20, 1996

Safe, broad-spectrum quinolones from Wakunaga

Sep. 20, 1996

Antibacterial compositions for MRSA

Sep. 20, 1996

New quinolone from Bayer undergoing extensive evaluation

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...